A

Arbutus Biopharma Corp
D

ABUS

3.20000
USD
0.01
(0.31%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-7
Market Cap
606,373,392
OverviewSignalsIdeasNews
Related Instruments
    A
    ADVM
    0.06000
    (1.28%)
    4.73500 USD
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    A
    ARWR
    -0.020
    (-0.10%)
    19.450 USD
    BMY
    BMY
    0.990
    (1.76%)
    57.280 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    MRNA
    MRNA
    -0.200
    (-0.51%)
    39.360 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    V
    VBIV
    0.000000
    (0.00%)
    0.000000 USD
    VRTX
    VRTX
    0.58
    (0.15%)
    397.15 USD
    More
News

Title: Arbutus Biopharma Corp

Sector: Healthcare
Industry: Biotechnology
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.